Related Experiment Video
Updated: Aug 6, 2026

07:06
Pentylenetetrazole-Induced Kindling Mouse Model
Published on: June 12, 2018
Microglia and its P2RY12 receptors regulate seizure severity
Leigh Ellen Fremuth1,2,3, Synphane Gibbs-Shelton1,4, Madison Doceti5
1Brain Immunology and Glia Center, University of Virginia, Charlottesville, VA, USA.
Iscience
|July 23, 2026
Summary
Microglia protect against seizures. Loss of microglia or P2RY12 signaling in microglia worsens seizure severity and network excitability, establishing them as key regulators of seizure activity.
Area of Science:
- Neuroscience
- Immunology
- Epilepsy Research
Background:
- Microglia, the brain's immune cells, are implicated in seizure regulation, but selective manipulation has been challenging.
- Previous studies lacked specificity, hindering definitive conclusions about microglial roles in epilepsy.
Purpose of the Study:
- To elucidate the specific role of microglia in seizure severity and the development of spontaneous recurrent seizures.
- To investigate the contribution of P2RY12 signaling within microglia to seizure control.
Main Methods:
- Utilized the microglial-deficient Csf1rΔFIRE/ΔFIRE mouse model for selective microglial absence.
- Employed two experimental paradigms to assess seizure activity in the absence of microglia and P2RY12.
- Analyzed microglial process complexity, neuronal activation, and inhibitory tone during seizures.
Main Results:
- Microglial deficiency exacerbated seizures and increased the likelihood of developing spontaneous recurrent seizures.
- Loss of P2RY12 signaling in microglia significantly increased seizure severity.
- P2RY12-deficient microglia showed altered morphology, increased neuronal activation, and reduced inhibitory tone during seizures.
Conclusions:
- Microglia act as critical suppressors of seizure activity and network hyperexcitability.
- P2RY12 signaling in microglia is essential for their protective role in regulating seizure severity.
- These findings identify microglia and P2RY12 as potential therapeutic targets for epilepsy.
